Related Experiment Video

Updated: Jan 13, 2026

Asymmetric Walkway: A Novel Behavioral Assay for Studying Asymmetric Locomotion
08:19

Asymmetric Walkway: A Novel Behavioral Assay for Studying Asymmetric Locomotion

Published on: January 15, 2016

9.3K

Is motor asymmetry a predictor of non-motor outcomes in Parkinson's disease?

Philippe Voruz1,2,3, Marc Vérin4,5, Julie Anne Péron6,7,8

  • 1Clinical and Experimental Neuropsychology Laboratory, Faculty of Psychology, Geneva, Switzerland.

Journal of Neural Transmission (Vienna, Austria : 1996)
|January 12, 2026
PubMed

Abstract:

The objective of this opinion paper is to highlight, based on recent studies, the importance of considering motor symptom (a)symmetry in the progression and management of non-motor symptoms in Parkinson's disease.

Keywords:
Non-motor SymptomsPsychiatry; PsychiatryCognitionEmotionMotor symptom asymmetry

More Related Videos

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

56.2K

Related Experiment Videos

Last Updated: Jan 13, 2026

Asymmetric Walkway: A Novel Behavioral Assay for Studying Asymmetric Locomotion
08:19

Asymmetric Walkway: A Novel Behavioral Assay for Studying Asymmetric Locomotion

Published on: January 15, 2016

9.3K
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.9K
Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

56.2K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

963
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
963

Articles linked to this work by shared authors, journal, and citation graph.

Gut oralisation signatures in Parkinson's disease: an integrative multi-study analysis.

Journal of oral microbiology·2026

Encompassing the complexity of personality to understand its association with disability in multiple sclerosis.

Journal of health psychology·2026

Cognitive trajectories of older adults before and after the COVID-19 pandemic: socioeconomic and psychological disparities in the Lc65+ cohort.

Innovation in aging·2026

Nationwide analysis of real-world access to and use of device-aided therapies in Parkinson's disease: insights from the French National Healthcare Data System (2015-2021).

BMJ neurology open·2026

Spatial clustering of anxiety and depression and determinants of high-risk areas in a Swiss urban population, 2023-2025.

Journal of affective disorders·2026

Spatial variations of sleep impairment indicators associated with night-time noise: A fine-scale population-based study.

Sleep health·2026

Impact of clinical risk factors on white matter microstructure in preterm-born infants: investigation with diffusion MRI and tractography at term-equivalent age.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Perceived problems in movement control at the piano among Japanese conservatory-trained classical pianists: a cross-sectional questionnaire survey screening for musician's dystonia.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Improving the clinical trial landscape for Parkinson syndromes in Germany.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Twenty-five years of progress in Parkinson's disease research: from dopamine replacement to biological definition and regenerative therapy.

Journal of neural transmission (Vienna, Austria : 1996)·2026

Marked intrafamilial phenotypic heterogeneity associated with the CSF1R c.2539G>A pathogenic variant in a Japanese family.

Journal of neural transmission (Vienna, Austria : 1996)·2026

The role of transcranial direct current stimulaton on ataxia: a scoping review.

Journal of neural transmission (Vienna, Austria : 1996)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us